SCHEMBL20907320

SCHEMBL20907320

CN1CCCN(c2ccc3c(c2)OCCO3)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.54
RAB9A P51151 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
PKM P14618 1/20 0.53
CYP2C19 P33261 1/20 0.53
DRD2 P14416 4/20 0.51
DRD3 P35462 4/20 0.51
HTR1A P08908 1/20 0.51
ADRA2A P08913 1/20 0.51
ADRA2C P18825 1/20 0.51
ADRA1D P25100 1/20 0.51
ADRA1A P35348 1/20 0.51
ADRA1B P35368 1/20 0.51
SIGMAR1 Q99720 1/20 0.51
DRD4 P21917 3/20 0.50
CHKA P35790 1/20 0.49
MEN1 O00255 1/20 0.48
ALDH1A1 P00352 1/20 0.48
KMT2A Q03164 1/20 0.48
HTT P42858 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14922286 0.94 SMN1; SMN2 (0.59) NPC1RAB9ASMN1; SMN2PKMCYP2C19
SCHEMBL13727501 0.83 NPC1 (0.59) NPC1RAB9ASMN1; SMN2CYP2C19ADRA2C
SCHEMBL20000624 0.83 DRD2 (0.50) NPC1RAB9ASMN1; SMN2PKMDRD2
SCHEMBL23646854 0.79 MAPT (0.57) NPC1RAB9ASMN1; SMN2PKMDRD2
SCHEMBL30061277 0.79 MAPT (0.57) NPC1RAB9ASMN1; SMN2PKMDRD2
SCHEMBL24434520 0.78 CMA1 (0.56) NPC1RAB9ADRD2DRD3DRD4
SCHEMBL20907277 0.76 CHKA (0.62) NPC1RAB9ASMN1; SMN2ADRA2CCHKA
SCHEMBL4950509 0.76 HTR1A (0.53) DRD2DRD3HTR1AADRA2AADRA2C
SCHEMBL5235512 0.75 TGFBR1 (0.51) NPC1RAB9ADRD2DRD3HTR1A
SCHEMBL15981860 0.75 DRD2 (0.52) NPC1RAB9ASMN1; SMN2DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019073251-A1 LYSYL OXIDASE INHIBITORS THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) 2019-04-18 WO disclosed